Long term open follow-up with H376/95 vs. warfarin
Study identifier:SH-TPA-0004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Terminated/Withdrawn
Official Title
Long-Term Treatment with the Oral Direct Thrombin Inhibitor Ximelagatran, Compared to Warfarin, as Stroke Prophylaxis in Patients with Atrial Fibrillation. A long term follow-Up Study
Medical condition
Stroke prevention in patients with atrial fibrillation
Phase
Phase 2
Healthy volunteers
No
Study drug
EXANTA
Sex
All
Actual Enrollment
220
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Aug 1999
Primary Completion Date: 01 Jun 2004
Study Completion Date: 01 Apr 2006
Study design
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
